![• Szerlip M, Singh G, and Luft UC. A Case of a Bloated Face: SVC syndrome. Journal of Interventional
Cardiology. 2011 May 1 (11).
• Szerlip M, Suryanarayana P, Luft UC. Anomalous Left Main Coronary Artery Arising from the Right
Coronary Cusp. Cardiac Cath Lab Director. 2011 Feb: 1 (1).
• Luft UC, Bychkov R, Gollasch M, Gross V, Roullet JB, McCarron DA, Ried C, Hofmann F, Yagil Y, Yagil
C, Haller H, Luft FC. Farnesol Inhibits L-Type Ca2+
Channels In Vascular Smooth Muscle Cells.
Arteriosclerosis Thrombosis Vascular Biology. 1999 Apr;19(4):959-66.
• Roullet JB, Luft UC, Xue H, Chapman J, Bychkov R, Roullet CM, Luft FC, Haller H, McCarron DA.
Farnesol Blocks The L-Type Ca2+
Channel By Targeting The Alpha 1C Subunit. J Biol Chem. 1999 Dec
19;272(51):32240-6.
• Roullet JB, Le Quan Sang KH, Luft UC, Watanabe M, Otsuka K, McCarron DA, Devynck MA. Inhibition
Of Ca2+ Uptake Into A7r5 Vascular Smooth Muscle Cells By Farnesol: Lack Of Effect On Membrane
Fluidity And Ca2+
-Atpase Activities. J Hypertens. 1997 Dec;15(12 Pt 2):1723-8.
• Roullet JB, Xue H, Luft UC, Roullet CM, McCarron DA. GTP-Binding (G) Protein Carboxyl Methylation
Controls Agonist Induced Intracellular Ca2+
Response In Rat Resistance Arteries And Aortic Vascular
Smooth Muscle Cells. American Journal of Hypertension. 1996 Apr; 9(4): C1 [Abstract].
Journal Editor/Reviewer:
• Journal of Interventional Cardiology, 2013-
• Cardiac Cath Lab Director. 2010
• Clinical Journal of the American Society of Nephrology. 2008-
Seminars:
• Deborah Heart and Lung Center, Cardiology Grand Rounds: Percutaneous Treatment of Structural Heart
Disease. 5/2012.
• University of Arizona, Medicine Grand Rounds: Transcatheter Aortic Valve Implantation – A New Therapy
for High Risk Surgical Patients. 6/2009.
• University of Arizona, Cardiology Grand Rounds: Percutaneous Coronary Intervention on Unprotected Left
Main Coronary Artery – A Paradigm Shift? 11/2009.
• University of Arizona, Cardiology Grand Rounds: Percutaneous Aortic Valve “Replacement” – The Cedars
Sinai Experience. 10/2008.
• Good Samaritian Hospital, Portland OR, Medicine Grand Rounds: Percutaneous Aortic Valve
“Replacement” – The Cedars Sinai Experience. 10/2008.
• OHSU Heart Research Center: Vitamin A (Retinol) and Vasoregulation – A new role for Vitamins? 6/30/06.
Invited to lecture by Dr. Kent Thornburg.
• OHSU Heart Research Center: ASIC3, CGRP, and Langendorff – Possible Mechanism of Hypoxic
Vasodilation. 10/01/05. Invited to lecture by Dr. Virginia Brooks.
• Max Delbrück Center: ASIC3, CGRP, and Langendorff – Possible Mechanism of Hypoxic Vasodilation.
3/10/05. Invited to lecture by Dr. Maik Gollasch.
• University of Vermont Pharmacology Seminar: Farnesol Inhibits L-Type Calcium Channels In VSCM.
8/9/97. Invited to lecture by Dr. Mark Nelson.
• OHSU Nephrology Seminar: Patch Clamp, Calcium Signaling, and Farnesol. 2/25/97. Invited to lecture by
Dr. David McCarron.
• University of Leipzig Research Seminar: Inhibition of L-type Calcium Channels With Farnesol. Invited to
lecture by Prof. Dr. med. W.A. Scherbaum.](https://image.slidesharecdn.com/d50ec8f4-d8b5-4f53-bbbc-c5e92357baac-160405150354/85/CV2016v4-4-320.jpg)
CV2016v4
- 1. Ulrich C. Luft, MD 44 NE Stanton Portland, OR 97239 ● 609-610-3334 ucluft@gmail.com Employment: Kaiser Permanente Portland, Oregon Attending Interventional Cardiologist, Endovascular Interventionalist, 9/2013-3/2016 Director of Structural Heart Program/TAVR program Director of Aortic Pathologies Program Credentialed Procedures: Coronary PCI, Peripheral interventions (iliac, femoral, pedals), Carotid stenting, EVAR, TEVAR, TAVR, MitraClip, HOCM septal ablation, PVL closure, PFO/ASD/VSD closure, DVT filters, Impella placement, coil embolization, (training and experience in Watchman), etc. Deborah Heart and Lung Institute Browns Mills, New Jersey Associate Professor of Clinical Medicine (Philadelphia College of Osteopathic Medicine) Interventional Cardiology and Endovascular Attending, 3/11-9/13 University of Arizona Tucson, Arizona Assistant Professor of Medicine, 3/2009 – 3/2011 Director of Cardiac Catheterization Lab, UA South/University Physician’s Hospital Education: Interventional Cardiology Fellowship: Cedars-Sinai/UCLA Los Angeles, California Interventional Cardiology Fellowship, 7/2007- 3/2009 Cardiology Fellowship: Oregon Heath Sciences University School of Medicine Portland, Oregon Cardiology Fellowship, 7/2003-7/2007 Internal Medicine Residency: Stanford University Stanford, California Internal Medicine Residency, 7/2001-7/2003 Medical School: Oregon Health Sciences University School of Medicine Portland, Oregon MD, Magna Cum Laude, 8/1997-7/2001 Undergraduate: Reed College Portland, Oregon BA, Mathematics, 8/1989 -7/1994
- 2. Board Certifications: • ABVM Endovascular Intervention, 2/11-2/21. • ABIM Interventional Cardiology, 11/2008 – 11/2018. • ABIM Cardiology, 11/2007 – 12/2017. • ABIM Internal Medicine, 8/2004 – 12/2014. Licenses: • Oregon Medical License, 7/2003 (active). • New Jersey Medical License, 1/2011 (inactive). • Arizona Medical License, 3/2009 (inactive). • Oregon Medical License, 7/2003 (inactive). • California Medical License, 7/2002 – 7/2009 (inactive). • Washington Medical License, 5/2005 (inactive). • DEA License, 3/2002 – 3/2017 (active). Honors: 3/2014: Facutly, ACC 9/2013: Faculty, TCT 3/2013: Faculty, ACC 10/2012: Faculty, TCT 4/2012: Faculty, SCAI 1/2012: Expert Faculty, LINC 7/2007: Cardiology Teaching Award 8/2006: Cardiology Chief Fellow, OHSU 7/2004: American Heart Association Grant Recipient 6/2001: Magna Cum Laude, OHSU Medical School 5/2000: Junior AOA 6/1994: Mathematics Thesis, Jν(x):A Short Treatise on Bessel Functions 6/1994: Award for Academic Excellence, Reed College Research: Deborah Heart and Lung Center (3/2011-Present): Co-primary Investigator • Analyze ST • LEVANT 2 • LEVANT 2 Registry • Visibility • Symplicity HTN-3 • IN-PACT SFA II • Excite • Sapphire • Choice • Canopy • Evolve II University of Arizona (3/2009-3/2011): Primary Investigator • PROVIDE Co-primary Investigator
- 3. • TIMI 52 • VISTA 16 • OSIRIS 403 Cedars Sinai Hospital (7/2007-3/2009): Co-primary Investigator • REVITALIZE (Stem cell study) • EPC (Stem cell study) • EVALVE EVEREST II • PROTECT II • WATCHMAN TRIAL • CHAMPION • CABG OUTCOMES • PARTNER TRIAL OHSU (7/2004-7/2007): American Heart Association Post Doctoral Fellowship Grant • Title: “Molecular Mechanisms of Angina” • Division of Cardiology • Primary investigator: Ed McCleskey OHSU (7/1994-7/2000): Research Assistant, Portland, Oregon • Division of Nephrology, Hypertension, and Clinical Pharmacology • Primary investigators: Jean-Baptist Roullet, David McCarron • Areas of study: Molecular and Cellular Biology • Responsibilities included designing and running experiments Max Delbrück Center of Molecular Medicine (6/1996-7/1997): Research Assistant, Berlin, Germany • Department of Cardiology and Nephrology • Primary investigators: Maik Gollasch, Herman Haller • Areas of study: Molecular Biology and Electrophysiology • Responsibilities included designing and running experiments Publications: • Sanghvi K, Selvarag N, Luft UC. Percutaneous closure of Perimembranous VSD Through an Arm Approach. Journal of Interventional Cardiology. April 2014. • Huynh N, Luft UC, Sanghvi K. Transradial Structural Intervention. Cath Lab Digest. November 2015 • Desai H, Van Hise A, Ng A, Luft UC. Trans-apical Closure of Mitral Perivalvular Leak. Journal of Cardiovascular Intervention (submitted 3/2013). • His D, Marreddy R, Moshiyakhov M, Luft UC, Regadenoson Induced Acute STEMI and Multivessel Coronary Thrombosis. Journal of Nuclear Cardiology. 2013 March. • Desai G, Selvaraj N, George J, Luft UC, Percutaneous Closure of a Complex VSD. Cath Lab Digest. 2013 January (1). • Desai H, George G, Luft UC, External Iliac Artery Stenosis as Etiology of Renal Failure Post-Kidney Transplant. Cath Lab Digest. 2012 May (5). • Hakimi M, George G, Luft UC, A Rare Diagnosis of Cardiac Amyloidosis Triggered by Cardiac Catheterization Findings. Cath Lab Digest. 2012 January (1). • Barnes B, Luft UC, Mogtader A, George J, Percutaneous Transcatheter Closure of a Mitral Paravalvular Leak. Cath Lab Digest. 2012 June (6). • Shanmugasundaram M, Ram VK, Luft UC, Szerlip M, Alpert JS. Peripheral Arterial Disease – What do we need to know? A Review. Clinical Cardiology. 2011.
- 4. • Szerlip M, Singh G, and Luft UC. A Case of a Bloated Face: SVC syndrome. Journal of Interventional Cardiology. 2011 May 1 (11). • Szerlip M, Suryanarayana P, Luft UC. Anomalous Left Main Coronary Artery Arising from the Right Coronary Cusp. Cardiac Cath Lab Director. 2011 Feb: 1 (1). • Luft UC, Bychkov R, Gollasch M, Gross V, Roullet JB, McCarron DA, Ried C, Hofmann F, Yagil Y, Yagil C, Haller H, Luft FC. Farnesol Inhibits L-Type Ca2+ Channels In Vascular Smooth Muscle Cells. Arteriosclerosis Thrombosis Vascular Biology. 1999 Apr;19(4):959-66. • Roullet JB, Luft UC, Xue H, Chapman J, Bychkov R, Roullet CM, Luft FC, Haller H, McCarron DA. Farnesol Blocks The L-Type Ca2+ Channel By Targeting The Alpha 1C Subunit. J Biol Chem. 1999 Dec 19;272(51):32240-6. • Roullet JB, Le Quan Sang KH, Luft UC, Watanabe M, Otsuka K, McCarron DA, Devynck MA. Inhibition Of Ca2+ Uptake Into A7r5 Vascular Smooth Muscle Cells By Farnesol: Lack Of Effect On Membrane Fluidity And Ca2+ -Atpase Activities. J Hypertens. 1997 Dec;15(12 Pt 2):1723-8. • Roullet JB, Xue H, Luft UC, Roullet CM, McCarron DA. GTP-Binding (G) Protein Carboxyl Methylation Controls Agonist Induced Intracellular Ca2+ Response In Rat Resistance Arteries And Aortic Vascular Smooth Muscle Cells. American Journal of Hypertension. 1996 Apr; 9(4): C1 [Abstract]. Journal Editor/Reviewer: • Journal of Interventional Cardiology, 2013- • Cardiac Cath Lab Director. 2010 • Clinical Journal of the American Society of Nephrology. 2008- Seminars: • Deborah Heart and Lung Center, Cardiology Grand Rounds: Percutaneous Treatment of Structural Heart Disease. 5/2012. • University of Arizona, Medicine Grand Rounds: Transcatheter Aortic Valve Implantation – A New Therapy for High Risk Surgical Patients. 6/2009. • University of Arizona, Cardiology Grand Rounds: Percutaneous Coronary Intervention on Unprotected Left Main Coronary Artery – A Paradigm Shift? 11/2009. • University of Arizona, Cardiology Grand Rounds: Percutaneous Aortic Valve “Replacement” – The Cedars Sinai Experience. 10/2008. • Good Samaritian Hospital, Portland OR, Medicine Grand Rounds: Percutaneous Aortic Valve “Replacement” – The Cedars Sinai Experience. 10/2008. • OHSU Heart Research Center: Vitamin A (Retinol) and Vasoregulation – A new role for Vitamins? 6/30/06. Invited to lecture by Dr. Kent Thornburg. • OHSU Heart Research Center: ASIC3, CGRP, and Langendorff – Possible Mechanism of Hypoxic Vasodilation. 10/01/05. Invited to lecture by Dr. Virginia Brooks. • Max Delbrück Center: ASIC3, CGRP, and Langendorff – Possible Mechanism of Hypoxic Vasodilation. 3/10/05. Invited to lecture by Dr. Maik Gollasch. • University of Vermont Pharmacology Seminar: Farnesol Inhibits L-Type Calcium Channels In VSCM. 8/9/97. Invited to lecture by Dr. Mark Nelson. • OHSU Nephrology Seminar: Patch Clamp, Calcium Signaling, and Farnesol. 2/25/97. Invited to lecture by Dr. David McCarron. • University of Leipzig Research Seminar: Inhibition of L-type Calcium Channels With Farnesol. Invited to lecture by Prof. Dr. med. W.A. Scherbaum.